Then, we identify that ARNTL induces G2/M phase arrest by targeting CDK5. Moreover, ARNTL could enhance the sensitivity of NPC cells to cisplatin in both vitro and vivo. Our findings provide new insights into potential mechanism of ARNTL regulating cell proliferation and clinical treatment for NPC. This evidence concerns the gene CDK5 and nasopharyngeal carcinoma.